Neoplasms, Neuroepithelial
Information
- Disease name
- Neoplasms, Neuroepithelial
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03911388 | Active, not recruiting | Phase 1 | HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors | September 12, 2019 | September 1, 2026 |
| NCT05592743 | Available | Vorasidenib Expanded Access Program | |||
| NCT03434262 | Completed | Phase 1 | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors | March 5, 2018 | May 24, 2024 |
| NCT05850377 | Not yet recruiting | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | June 1, 2023 | May 31, 2026 | |
| NCT01579253 | Unknown status | Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients | April 2012 | ||
| NCT04388033 | Unknown status | Phase 1/Phase 2 | Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. | December 2020 | December 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D018302